Newsletter | April 7, 2021

04.07.21 -- Astellas' CMO & President Of Development Talks Best Practices

Featured Articles
A Q&A With Bernie Zeiher Of Astellas

Bernie Zeiher, of Astellas, took on the dual role of CMO and president of development in April 2018. Here he discusses how he adjusted to that job and some of the best practices he’s learned along the way.

Insights On How Outsourcing Decisions Are Made

How does your company’s approach to making outsourcing decisions compare with others in the industry? Data from ISR’s CDMO outsourcing models report highlights common practices that, when adopted, may improve outsourcing outcomes from drug innovators’ perspectives.

180 Life Sciences: Deliberately Seeking Serendipity

At 180 Life Sciences, veterans of the old-pharma world are building a small bio enterprise focused evenly on scientific and market opportunities in the inflammation space.

How A New Biopharma CEO Approaches Diversity And Inclusion

Michael McCullar, Ph.D., who joined OnQuality Pharmaceuticals as the company’s CEO in December 2020, shares thoughts on his approach to diversity and inclusion (D&I) as a newly appointed leader.

027: Announcing Our Special Edition Series

Starting in April, we will be releasing the audio portion of our popular Executive Virtual Roundtables.

Improving Diversity In Clinical Trials

The lack of diversity in clinical trials isn’t a new problem, but in 2020 this issue rose to the forefront of the industry as a spotlight was cast on drug development as a whole due to the COVID-19 pandemic. 

April 2021 Digital Edition

Inside you will find more on:

  • Leadership Lessons
  • Clinical Trials
  • Outsourcing Research
  • CEO Corner

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.